Neuland Laboratories Ltd

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 15 May 2025.Powered by Capital Market - Live

Neuland Laboratories Ltd gained 2.02% today to trade at Rs 13000. The BSE Healthcare index is up 0.35% to quote at 41465.13. The index is up 2.44 % over last one month. Among the other constituents of the index, Wockhardt Ltd increased 1.79% and Narayana Hrudayalaya Ltd added 1.75% on the day. The BSE Healthcare index went up 18.45 % over last one year compared to the 5.39% surge in benchmark SENSEX. Neuland Laboratories Ltd has added 14.87% over last one month compared to 2.44% gain in BSE Healthcare index and 2.09% rise in the SENSEX. On the BSE, 29 shares were traded in the counter so far compared with average daily volumes of 2530 shares in the past one month. The stock hit a record high of Rs 18089.55 on 04 Dec 2024. The stock hit a 52-week low of Rs 5557 on 04 Jun 2024.Powered by Capital Market - Live

Neuland Laboratories announced that Parag Deshmukh has been appointed as Head - Manufacturing w.e.f. 10 March 2025.Powered by Capital Market - Live

Neuland Laboratories announced that India Ratings and Research has affirmed the credit rating assigned to the Company as under: Long term - IND A+/Positive Fund-Based Limits - IND A+/Positive / IND A1 Non-Fund Based limits - IND A1 Powered by Capital Market - Live

Vesuvius India Ltd, Pfizer Ltd, Data Patterns (India) Ltd and Orchid Pharma Ltd are among the other gainers in the BSE's 'A' group today, 24 February 2025.Neuland Laboratories Ltd spiked 10.62% to Rs 12164.7 at 11:47 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 2963 shares were traded on the counter so far as against the average daily volumes of 1843 shares in the past one month. Vesuvius India Ltd surged 6.76% to Rs 4084.95. The stock was the second biggest gainer in 'A' group. On the BSE, 1309 shares were traded on the counter so far as against the average daily volumes of 767 shares in the past one month. Pfizer Ltd soared 6.02% to Rs 4340.95. The stock was the third biggest gainer in 'A' group. On the BSE, 16599 shares were traded on the counter so far as against the average daily volumes of 1684 shares in the past one month. Data Patterns (India) Ltd advanced 5.76% to Rs 1643.65. The stock was the fourth biggest gainer in 'A' group. On the BSE, 40437 shares were traded on the counter so far as against the average daily volumes of 29406 shares in the past one month. Orchid Pharma Ltd jumped 5.00% to Rs 966.15. The stock was the fifth biggest gainer in 'A' group. On the BSE, 9903 shares were traded on the counter so far as against the average daily volumes of 13157 shares in the past one month. Powered by Capital Market - Live

Neuland Laboratories Ltd lost 3.78% today to trade at Rs 13142.7. The BSE Healthcare index is down 0.71% to quote at 40715.74. The index is down 4.34 % over last one month. Among the other constituents of the index, Wockhardt Ltd decreased 3.51% and Sequent Scientific Ltd lost 3.22% on the day. The BSE Healthcare index went up 15.34 % over last one year compared to the 6.43% surge in benchmark SENSEX. Neuland Laboratories Ltd has added 0.38% over last one month compared to 4.34% fall in BSE Healthcare index and 0.23% drop in the SENSEX. On the BSE, 65 shares were traded in the counter so far compared with average daily volumes of 1407 shares in the past one month. The stock hit a record high of Rs 18089.55 on 04 Dec 2024. The stock hit a 52-week low of Rs 5532.5 on 14 Mar 2024.Powered by Capital Market - Live

Net profit of Neuland Laboratories rose 24.82% to Rs 101.59 crore in the quarter ended December 2024 as against Rs 81.39 crore during the previous quarter ended December 2023. Sales rose 1.32% to Rs 398.03 crore in the quarter ended December 2024 as against Rs 392.83 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales398.03392.83 1 OPM %21.7630.87 - PBDT88.29119.62 -26 PBT71.98104.48 -31 NP101.5981.39 25 Powered by Capital Market - Live

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live

Bajaj Holdings & Investment Ltd, South Indian Bank Ltd, Multi Commodity Exchange of India Ltd and Easy Trip Planners Ltd are among the other gainers in the BSE's 'A' group today, 22 January 2025.Neuland Laboratories Ltd surged 4.76% to Rs 13824.45 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 1095 shares were traded on the counter so far as against the average daily volumes of 1158 shares in the past one month. Bajaj Holdings & Investment Ltd soared 4.23% to Rs 11250. The stock was the second biggest gainer in 'A' group. On the BSE, 5247 shares were traded on the counter so far as against the average daily volumes of 3414 shares in the past one month. South Indian Bank Ltd spiked 3.57% to Rs 26.72. The stock was the third biggest gainer in 'A' group. On the BSE, 27.73 lakh shares were traded on the counter so far as against the average daily volumes of 18.98 lakh shares in the past one month. Multi Commodity Exchange of India Ltd exploded 3.14% to Rs 5676.75. The stock was the fourth biggest gainer in 'A' group. On the BSE, 27430 shares were traded on the counter so far as against the average daily volumes of 20369 shares in the past one month. Easy Trip Planners Ltd jumped 2.83% to Rs 14.15. The stock was the fifth biggest gainer in 'A' group. On the BSE, 55.07 lakh shares were traded on the counter so far as against the average daily volumes of 58.87 lakh shares in the past one month. Powered by Capital Market - Live

The pharma company plans to expand the peptide synthesizer reactor capacity at its Unit-1 in Bonthapally Village, Sangareddy District, Telangana, from 0.5 KL to 6.37 KL by FY27. The Rs 254 crore capital expenditure will support the development and commercial production of peptides for its GDS & CMS business. Additionally, the company's board has also approved an investment of Rs 88 crore towards building an additional capacity of 52 KL in its Unit-3 located at Gaddapotharam Village, Sangareddy District in Telangana. This capacity expansion is expected to be completed in 15 to 18 months. The capex is aimed at meeting the growing demand from customers. Neuland Laboratories is engaged in the manufacturing and selling of bulk drugs and caters to both domestic and international markets. The company reported a consolidated net profit slipped 63.2% to Rs 32.84 crore on 25.6% decline in net sales to Rs 310.84 crore in Q2 FY25 over Q2 FY24. Powered by Capital Market - Live